PPA
ADMS

Parametric Portfolio Associates’s Adamas Pharmaceuticals ADMS Stock Holding History

Parametric Portfolio Associates’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-21,790
Closed -$111K – 4019
2019
Q3 		$111K Sell
21,790
-6,146
-22% -$37.9K ﹤0.01% 3817
2019
Q2 		$173K Buy
+27,936
New +$161K ﹤0.01% 3764
2019
Q1 		– Sell
-27,411
Closed -$234K – 3989
2018
Q4 		$234K Sell
27,411
-15,548
-36% -$202K ﹤0.01% 3606
2018
Q3 		$860K Sell
42,959
-1,920
-4% -$45.1K ﹤0.01% 3181
2018
Q2 		$1.16M Sell
44,879
-68,309
-60% -$1.89M ﹤0.01% 2976
2018
Q1 		$2.71M Sell
113,188
-16,203
-13% -$511K ﹤0.01% 2394
2017
Q4 		$4.38M Sell
129,391
-2,496
-2% -$69.7K ﹤0.01% 2015
2017
Q3 		$2.79M Buy
131,887
+23,178
+21% +$425K ﹤0.01% 2344
2017
Q2 		$1.9M Sell
108,709
-3,079
-3% -$50.9K ﹤0.01% 2562
2017
Q1 		$1.96M Buy
111,788
+67,654
+153% +$1.15M ﹤0.01% 2461
2016
Q4 		$746K Sell
44,134
-30,965
-41% -$479K ﹤0.01% 2996
2016
Q3 		$1.23M Buy
75,099
+2,723
+4% +$41.4K ﹤0.01% 2668
2016
Q2 		$1.1M Buy
72,376
+33
+0% +$544 ﹤0.01% 2761
2016
Q1 		$1.05M Buy
+72,343
New +$1.22M ﹤0.01% 2892

Other funds holding ADMS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Parametric Portfolio Associates's ADMS Position: Q4 2019 in Review

Parametric Portfolio Associates sold out of Adamas Pharmaceuticals (ADMS) in Q4 2019, closing a stake of 21,790 shares — an estimated $111K sold.

Parametric Portfolio Associates first reported a position in ADMS in Q1 2016 and held it in 14 quarters. The position peaked at $4.38M in Q4 2017. 79 funds tracked by Wall St. Rank hold ADMS as of Q4 2019.

  • Parametric Portfolio Associates reported no remaining Adamas Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 21,790 Adamas Pharmaceuticals shares in Q4 2019, an estimated $111K.
  • Parametric Portfolio Associates first reported a position in Adamas Pharmaceuticals in Q1 2016 and held it in 14 quarters.
  • Parametric Portfolio Associates's Adamas Pharmaceuticals position peaked at $4.38M in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2019.

Based on Parametric Portfolio Associates's 13F filing for Q4 2019, filed 14 Feb 2020.